• Study on the Effectiveness and Safety of Golcadomide and Rituximab for Patients with Newly Diagnosed Advanced Follicular Lymphoma

    Not recruiting

    2 1 1 1
    France Germany Italy Poland Spain
  • Study of Pembrolizumab and Lenvatinib for Patients with Malignant Pleural Mesothelioma in Second and Third Line Treatment

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    The Netherlands
  • Study on Enzalutamide and Drug Combination for High-Risk Localized Prostate Cancer Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Austria Ireland Spain
  • Study on the Long-Term Effects of TEV-48574 (Duvakitug) for Adults with Moderate to Severe Ulcerative Colitis or Crohn’s Disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Bulgaria Czechia Germany Hungary Italy +4
  • Long-term Study of Sotatercept for Adults with Pulmonary Arterial Hypertension (PAH)

    Not recruiting

    3 1 1
    Investigated Drugs:
    Austria Belgium Croatia Czechia Denmark France +8
  • Study on the Effectiveness and Safety of Osimertinib for Patients with Early-Stage Non-Small Cell Lung Cancer After Tumor Removal

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Italy Poland Romania Spain
  • Study Comparing MAB-22 and Denosumab for Treating Osteoporosis in Postmenopausal Women

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Czechia Poland
  • Study on the Effects of Calcium, Tacrolimus, and Mycophenolate Mofetil in Patients with Kidney Transplants

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Norway
  • Study of Nivolumab for Children and Adults with Relapsed or Refractory ALK+ Anaplastic Large Cell Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Denmark France
  • Study on Dobutamine and Tocilizumab for Patients with Heart Attack at High Risk of Cardiogenic Shock

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark

powered by